Profile
Dr. Domingo Rodriguez, MD, is an Executive VP-Global Clinical Operations at Veru, Inc. Dr. Rodriguez was previously employed as a Vice President-Global Development Operations by Mallinckrodt Pharmaceuticals Ltd., a Vice President-Clinical Operations by GTx, Inc., and a Medical Director-Medical Science Liaison by ICOS Corp.
Domingo Rodriguez active positions
| Companies | Position | Start |
|---|---|---|
| VERU INC. | Chief Tech/Sci/R&D Officer | 01/04/2018 |
Former positions of Domingo Rodriguez
| Companies | Position | End |
|---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/04/2018 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Chief Tech/Sci/R&D Officer | 11/05/2012 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Chief Tech/Sci/R&D Officer | 01/01/2004 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Veru, Inc.
Veru, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, markets and sells female condoms and develops drugs for cancer treatment | Health Technology |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Domingo Rodriguez
















